The FDA just approved esketamine for the indication of suicidality this month. Ketamine, which is similar to esketamine, has been used off-label for anxiety, OCD, substance use disorders, pain, PTSD, among others. However the data has not been strong enough to receive FDA approval for these other indications.

Take a free mental health quiz
Book an Appointment